Functional
characterization of genes can be determined by disruption of gene expression.
This provides powerful approach in designing novel treatment strategies. RNA
interference (RNAi) is a natural phenomenon that can aid in the study of
post-transcriptional regulation of genes. This mechanism can be stimulated via
introduction of double stranded RNA (dsRNA) in a cell. Synthetic short/small interfering
RNAs (siRNA) can be utilized to trigger down-regulation of desired genes via
transfecting into mammalian cells. Recently, utilization of bio-based polymers
has been an attractive approach in drug delivery for medical applications. This
review article describes the advantages of exploiting bio-based polymeric
carriers for siRNA targeting, as bio-therapeutics. Here, we report the current
developments, safety and delivery of bio-based siRNAs via polymeric carriers.
Additionally, cancer genetics and metabolic disorders including obesity and
diabetes pertaining to the progress in clinical applications have been
highlighted.
Journal Section | Review |
---|---|
Authors | |
Publication Date | February 28, 2018 |
Published in Issue | Year 2018 Volume: 7 Issue:1 |